Navigation Links
Global Biologic Drugs Market to Jump to Over $220 Billion by 2019 says Latest Report
Date:11/21/2013

DUBLIN, Ireland, November 21, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/q6n3x8/biologics_and) has announced the addition of the "Biologics and Biosimilars World Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Biologics, also known as biopharmaceuticals, can be categorized into three main modalities: therapeutic proteins, monoclonal antibodies and vaccines. Most of the biologic drugs marketed so far are recombinant therapeutic protein drugs, which are used to relieve patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular diseases, infertility and cystic fibrosis. Globally, the U.S. commands 43% of biologics sales, followed by the E.U. (21%) and Japan (9%).

The "Expanding Markets for Biologics and Biosimilars" report covers key biologic and biosimilar drugs, including:

  • Humira (Adalimumab)
  • Remicade (Infliximab)
  • Lantus (Insulin Glargine)
  • Levemir (Insulin Detemir)
  • Privigen (Immune Globulin Intravenous)
  • Perjeta (Pertuzumab)
  • Soliris (Eculizumab)
  • Eylea (Aflibercept)
  • Revlimid (Lenalidomide)
  • Herceptin (Trastuzumab)
  • Gardasil
  • Varivax (Varicella Virus Vaccine Live)
  • Gammagard Liquid (Immune Globulin Infusion (Human))
  • Aranesp (Darbepoetin Alfa)
  • Enbrel (Etanercept)
  • Epogen/Procrit/Eprex/Erypo (Epoetin Alfa)
  • Genotropin (Somatropin)
  • Herceptin (Trastuzumab)
  • Humira (Adalimumab)
  • Neulasta (Pegfilgrastim)
  • Neupogen (Filgrastim)
  • Remicade (Infliximab)
  • Rituxan/MabThera (Rituximab)

The "Expanding Markets for Biologics and Biosimilars" report examines companies manufacturing biologic and biosimilar equipment and supplies in the world.

Companies covered include:

- AbbVie, Inc
- Abbott Laboratories
- Actelion Ltd
- Amgen, Inc
- Amoytop Biotech Co, Ltd
- Anhui Anke Biotechnology (Group) Co, Ltd
- Apotex, Inc
- Astellas Pharma, Inc
- AstraZeneca
- Bayer AG
- Beijing Four Rings Biopharmaceuticals
- Bharat Serums and Vaccines Limited
- Bio, Inc
- Biocon Ltd
- Biogen Idec, Inc
- Bioton SA
- Boehringer Ingelheim Pharmaceuticals, Inc
- Bristol-Myers Squibb, Co
- Celgene Corporation
- Celltrion, Inc
- Cipla Ltd
- Dr Reddy's Laboratories Ltd
- Elan Corporation, PLC
- Eli Lilly & Co
- Gideon Richter
- Gilead Sciences, Inc
- GlaxoSmithKline PLC
- Hospira, Inc
- Intas Pharmaceuticals Limited
- Johnson & Johnson
- Merck & Co, Inc
- Mylan, Inc
- Novartis AG
- Pfizer, Inc
- Roche Holdings AG
- Sandoz International GmbH
- Sanofi
- Stada Arzneimittel Aktiengesellschaft
- Teva Pharmaceutical Industries Limited
- Watson Pharmaceuticals, Inc 

Detailed charts with sales forecasts and marketshare data are included.

For more information visit http://www.researchandmarkets.com/research/q6n3x8/biologics_and

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. High Temperature Plastics - Making Conventional Material Obsolete - Global Strategic Business Report 2013
2. Neurology Devices Market (CSF Shunts, CSF Drainage, Clot Retriever, Snare, Embolic Coil, Flow Diversion, Neurosurgery & Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
3. Global Medical Antimicrobial Coatings Market 2012-2016
4. Ophthalmic Instrumentation - Global Strategic Business Report - 2012 Featuring Abbott, Bausch & Lomb, Carl Zeiss and Others
5. Laboratory Glassware And Plasticware - 2012 Global Strategic Business Report Profiles 91 Companies Including Many Key and Niche Players
6. Blood Processing Supplies and Equipment - Global Strategic Business Report
7. Intravenous Equipment - Global Strategic Business Report
8. Global Medical Laser Systems Market Report 2013-2018: Global Aesthetics Laser Market Poised to Grow
9. Global Coagulation Self-Testing Devices, Markets, Players and Prospects Report 2013
10. Global Point-of-Delivery Drug Reconstitution Systems Market Report 2013 - 2017
11. Noser Engineering AG Expand Medical Device Technology Offering Meeting the Needs of Global Regulatory Compliance and Accelerating Time to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):